ULTRESA
ULTRESA
Discontinued
DIN Number
02045834
Drug Class
Human
Market Date
Jan 20, 1998
Company
HC
Aptalis Pharma Canada ULC
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02045834
AIG Number0302964034
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
A09AA02 MULTIENZYMES (LIPASE, PROTEASE ETC)
Product Specifications
Dosage FormCapsule (Delayed Release)
Route of AdministrationOral
AHFS Classification56:16.00
Health Canada Classification
ACTIVE INGREDIENTS (3)
AMYLASEActive
Strength: 58800 UNIT
Monograph: AMYLASE
LIPASEActive
Strength: 13800 UNIT
Monograph: LIPASE
PROTEASEActive
Strength: 53400 UNIT
Monograph: PROTEASE